Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYCLOBENZAPRINE Cause Drug abuse? 873 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 873 reports of Drug abuse have been filed in association with CYCLOBENZAPRINE (Cyclobenzaprine hydrochloride). This represents 9.5% of all adverse event reports for CYCLOBENZAPRINE.

873
Reports of Drug abuse with CYCLOBENZAPRINE
9.5%
of all CYCLOBENZAPRINE reports
781
Deaths
104
Hospitalizations

How Dangerous Is Drug abuse From CYCLOBENZAPRINE?

Of the 873 reports, 781 (89.5%) resulted in death, 104 (11.9%) required hospitalization, and 45 (5.2%) were considered life-threatening.

Is Drug abuse Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CYCLOBENZAPRINE. However, 873 reports have been filed with the FAERS database.

What Other Side Effects Does CYCLOBENZAPRINE Cause?

Toxicity to various agents (1,854) Pain (1,494) Completed suicide (1,438) Drug hypersensitivity (1,094) Constipation (1,057) Drug ineffective (954) Off label use (800) Fall (796) Hypotension (769) Headache (736)

What Other Drugs Cause Drug abuse?

FENTANYL (12,390) OXYCODONE (11,835) ALPRAZOLAM (8,827) MORPHINE (6,636) COCAINE (6,113) DIAZEPAM (5,609) ALCOHOL (5,596) ACETAMINOPHEN\HYDROCODONE (4,675) TRAMADOL (4,553) METHADONE (4,480)

Which CYCLOBENZAPRINE Alternatives Have Lower Drug abuse Risk?

CYCLOBENZAPRINE vs CYCLOPENTOLATE CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE FOR , USP CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\RITUXIMAB\VINCRISTINE CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\VINCRISTINE

Related Pages

CYCLOBENZAPRINE Full Profile All Drug abuse Reports All Drugs Causing Drug abuse CYCLOBENZAPRINE Demographics